Biopharmaceutical executive specializing in Corporate Strategy & Product Development• Breadth of Experience: Comprehensive approach to company building and value creation informed by 20+ years of experience spanning 13 functions, all phases of product development, and diverse company stages• End-to-End Roles: In-depth understanding of key functions along the biotech value chain, including research, early- & late-development, regulatory affairs, manufacturing, supply chain, program management, program finance, alliance management, business development, business operations, and commercial pricing & contracting• Global Product Development: Program leadership across all phases of development, including discovery, candidate selection, pre-clinical, early- & late-stage development, regulatory approval, and commercialization; integrated oversight enabled by prior functional experience o Drug Modalities: Small molecules, biologics, delivery devices / combination products, cell therapy, and gene therapy (mRNA, AAV) o Therapeutic Areas: Oncology, immunology, immuno-oncology, respiratory, infectious disease, ophthalmology, neurology, mental health, and orphan/rare• Distinct Company Stages & Operating Environments: Leadership and advisory roles at companies ranging in size and complexity from top-tier multinational (Genentech) to mid-sized, publicly traded (Coherus BioSciences, Confidential Client 1, Confidential Client 2) to Series A/B startup (Elixirgen Therapeutics, Retromer Therapeutics, Soley Therapeutics) • Trusted CEO Advisor: Established ability to integrate all aspects of the business (product, competitive, legal, financial, and stakeholder) to enable CEO- and Board-level decision making; demonstrated track record of defining priorities, structuring initiatives, driving Executive Team operations, and owning Board Meeting preparations